- Home
- HUBG vs HCM Comparison
HUBG vs HCM Comparison
Compare HUBG & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBG
- HCM
- Stock Information
- Founded
- HUBG 1971
- HCM 2000
- Country
- HUBG United States
- HCM Hong Kong
- Employees
- HUBG N/A
- HCM N/A
- Industry
- HUBG Oil Refining/Marketing
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- HUBG Consumer Discretionary
- HCM Health Care
- Exchange
- HUBG Nasdaq
- HCM Nasdaq
- Market Cap
- HUBG 2.8B
- HCM 2.6B
- IPO Year
- HUBG 1996
- HCM N/A
- Fundamental
- Price
- HUBG $38.01
- HCM $15.90
- Analyst Decision
- HUBG Buy
- HCM Hold
- Analyst Count
- HUBG 10
- HCM 1
- Target Price
- HUBG $47.30
- HCM $19.00
- AVG Volume (30 Days)
- HUBG 796.3K
- HCM 100.4K
- Earning Date
- HUBG 04-24-2025
- HCM 03-19-2025
- Dividend Yield
- HUBG 1.32%
- HCM N/A
- EPS Growth
- HUBG N/A
- HCM N/A
- EPS
- HUBG 1.70
- HCM 0.04
- Revenue
- HUBG $3,946,390,000.00
- HCM $630,201,000.00
- Revenue This Year
- HUBG $5.97
- HCM $28.98
- Revenue Next Year
- HUBG $6.93
- HCM $20.41
- P/E Ratio
- HUBG $22.26
- HCM $73.16
- Revenue Growth
- HUBG N/A
- HCM N/A
- 52 Week Low
- HUBG $36.04
- HCM $12.84
- 52 Week High
- HUBG $53.21
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- HUBG 45.02
- HCM 54.67
- Support Level
- HUBG $36.50
- HCM $14.72
- Resistance Level
- HUBG $38.54
- HCM $16.44
- Average True Range (ATR)
- HUBG 0.98
- HCM 0.52
- MACD
- HUBG 0.23
- HCM 0.01
- Stochastic Oscillator
- HUBG 78.80
- HCM 71.97
About HUBG Hub Group Inc.
Hub Group ranks among the largest providers of rail intermodal service. Roughly 60% of revenue comes from Hub's intermodal and transportation solutions division. ITS includes its flagship intermodal operations, which use the Class I rail carriers for the underlying line-haul movement of containers, as well as its dedicated truckload shipping unit. Hub's logistics segment includes its asset light truck brokerage operations, along with its outsourced transportation management, warehousing and fulfillment, and heavy-goods final mile delivery offerings. Hub is somewhat acquisitive in that it often makes tuck-in acquisitions which expand its brokerage, last-mile, and dedicated offerings.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.